BQR-695 is primarily utilized in the field of medical research, particularly in the development of treatments for chronic and acute diseases. Its application is significant in the study of inflammatory responses and immune system modulation. Researchers are exploring its potential as a therapeutic agent in autoimmune disorders, where it may help in reducing inflammation and preventing tissue damage. Additionally, BQR-695 is being investigated for its efficacy in oncology, particularly in enhancing the effectiveness of chemotherapy and reducing the side effects associated with cancer treatments. Its role in inhibiting specific pathways that contribute to tumor growth and metastasis is of particular interest. Furthermore, BQR-695 is being studied for its potential use in managing chronic pain and neurodegenerative diseases, offering hope for improved quality of life for patients suffering from these conditions.